Results 151 to 160 of about 1,221,694 (269)
Circular RNA CCT3 is a unique molecular marker in bladder cancer. [PDF]
Luo L +6 more
europepmc +1 more source
Diversity analysis of some selected rice genotypes through SSR- based molecular markers
M. H. Shahriar +3 more
openalex +2 more sources
Canadian Sarcoma GroupWorkshopSarcomas: Molecular Markers to Therapeutics,26–27 February 2000,Toronto, Canada [PDF]
Vivien Bramwell +26 more
openalex +1 more source
Genetic divergence between sub-accessions of the melon using molecular markers
Clisneide Coelho de Amorim +4 more
openalex +1 more source
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Molecular-Marker-Based Design for Breeding Indica-Japonica Hybrid Rice with Bacterial Blight Resistance. [PDF]
Dong J, Zhang X, Li Y, Fu H.
europepmc +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Discovery of Germplasm Resources and Molecular Marker-Assisted Breeding of Oilseed Rape for Anticracking Angle. [PDF]
Zhu C, Li Z, Liu R, Huang T.
europepmc +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source

